About 10.5M results
Open links in new tab
Sanofi's tolebrutinib drug delays progressive MS by 31% in trial
Sanofi wins US approval for multiple myeloma drug in newly
Sanofi eyes approval after MS therapy slows disease progression …
Latest Sanofi Press Releases and News | Sanofi
Sanofi pushes ahead with €20bn consumer healthcare spin-off
Sanofi Pipeline Transformation to Accelerate Growth Driven by …
Press Room - Sanofi US News
Press Room - Sanofi US News
Press Room - Sanofi US News
Sanofi Says Tolebrutinib Drug Delayed Progressive MS by 31% - U.S. News